Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia
Titel:
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia
Auteur:
Stephens, Deborah M. Ruppert, Amy S. Maddocks, Kami Andritsos, Leslie Baiocchi, Robert Jones, Jeffrey Johnson, Amy J. Smith, Lisa L. Zhao, Yuan Ling, Yonghua Li, Junan Phelps, Mitch A. Grever, Michael R. Byrd, John C. Flynn, Joseph M.